Information  X 
Enter a valid email address

Lifeline Scientific (LSI)

  Print      Mail a friend

Wednesday 22 June, 2011

Lifeline Scientific

Grant of options

RNS Number : 8674I
Lifeline Scientific, Inc
22 June 2011
 



22 June 2011

 

Lifeline Scientific, Inc.

("Lifeline" or the "Company")

 

Grant of options

 

 

Lifeline Scientific, the medial technology company focused on the worldwide commercialisation of its LifePort Kidney Transporter, a product designed to address the global challenge of human donor organ shortages, announces that on 16 June 2011 it granted a total of 575,000 options over common shares with an exercise price of GBP£2.125.  The options vest over the first 4 years from the date of issue, being 1 June 2011, at a rate of 25 per cent. per annum and are exercisable for a period of 10 years.

 

Included in that grant of options are the following option awards to members of the Board and senior management:

 

David Kravitz

250,000

Lisa Kieres

40,000

John Garcia

15,000

Klaas de Boer

15,000

Andrew Clark

15,000

Steven Mayer

15,000

Eric Swenden

15,000

 

 

 

Enquiries:

 

Lifeline Scientific, Inc.

+ 1 847 294 0300

David Kravitz, CEO


Seymour Pierce

+44 (0)20 7107 8000

Sarah Jacobs (Corporate Finance)


David Banks (Corporate Broking)


Financial Dynamics

+44 (0)20 7831 3113

Ben Brewerton


 

 

 

 

About the LifePort Kidney Transporter

Created with the challenges of organ recovery and transport in mind, LifePort Kidney Transporter is designed to provide improved kidney preservation, evaluation and transport prior to transplantation.  LifePort provides a sealed, sterile, protected environment where a solution is gently pumped through the kidney at cold temperatures to minimize damage while the organ is outside the body.  LifePort is lightweight and portable, allowing organs to be perfused from the time of recovery until transplant.  It is designed to travel unaccompanied by land or air, safely transporting the kidneys across town or between countries.  While the kidney is being perfused, the LifePort records data on temperature, flow rate vascular resistance and pressure every 10 seconds providing surgeons with additional data prior to transplant.    

 

About Lifeline Scientific Inc.

Lifeline Scientific, Inc. is a Chicago-based global medical technology company with European headquarters located in Brussels.  Its primary focus is to commercialise its FDA approved, CE marked, clinically validated and revenue generating LifePort Kidney Transporter. Devices for preservation of the heart, lung pancreas and liver are in late stage pre-clinical development.

 

For further information please see www.lifeline-scientific.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSVFLFLFQFZBBL